13F HOLDINGS REPORT
Kinnevik AB (publ)
Quarter ended Q4 2024 · Filed January 23, 2025 · Accession 0001104659-25-005615
Total Value
$80.5M
Positions
1
Other Managers
1
Confidential Omitted
No
Holdings (1)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Recursion Pharmaceuticals, Inc. | RXRX | 11,905,668 | $80.5M | 100.00% |